BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30953180)

  • 1. Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative.
    Stienen S; Ferreira JP; Girerd N; Duarte K; Lamiral Z; McMurray JJV; Pitt B; Dickstein K; Zannad F; Rossignol P;
    Clin Res Cardiol; 2019 Nov; 108(11):1215-1225. PubMed ID: 30953180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative.
    von Lueder TG; Girerd N; Atar D; Agewall S; Lamiral Z; Kanbay M; Pitt B; Dickstein K; Zannad F; Rossignol P;
    Eur J Heart Fail; 2015 Nov; 17(11):1144-51. PubMed ID: 26424212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction.
    Lopes RD; Pieper KS; Stevens SR; Solomon SD; McMurray JJ; Pfeffer MA; Leimberger JD; Velazquez EJ
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27353607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.
    Inglis SC; Bebchuk J; Al-Suhaim SA; Case J; Pfeffer MA; Solomon SD; Hou YR; Pitt B; Dargie HJ; Ford I; Kjekshus J; Zannad F; Dickstein K; McMurray JJ
    Int J Cardiol; 2013 Sep; 168(2):1094-101. PubMed ID: 23194780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database Initiative.
    Ferreira JP; Duarte K; Pfeffer MA; McMurray JJV; Pitt B; Dickstein K; Zannad F; Rossignol P;
    Eur J Heart Fail; 2018 Feb; 20(2):323-331. PubMed ID: 29314455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction.
    Hall TS; von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Dickstein K; Atar D; Agewall S; Girerd N;
    Int J Cardiol; 2018 Dec; 272():260-266. PubMed ID: 30144995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction.
    Shah AM; Pfeffer MA; Hartley LH; Moyé LA; Gersh BJ; Rutherford JD; Lamas GA; Rouleau JL; Braunwald E; Solomon SD
    Am J Cardiol; 2010 Oct; 106(7):911-6. PubMed ID: 20854949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction.
    Hall TS; von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Solomon SD; Dickstein K; Atar D; Agewall S; Girerd N;
    Am Heart J; 2019 Sep; 215():83-90. PubMed ID: 31291604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
    Janardhanan R; Kenchaiah S; Velazquez EJ; Park Y; McMurray JJ; Weaver WD; Finn PV; White HD; Marin-Neto JA; O'Connor C; Pfeffer MA; Califf RM; Solomon SD;
    Am Heart J; 2006 Jul; 152(1):183-9. PubMed ID: 16824854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A history of diabetes predicts outcomes following myocardial infarction: an analysis of the 28 771 patients in the High-Risk MI Database.
    Tajik AA; Dobre D; Aguilar D; Kjekshus J; Zannad F; Dickstein K;
    Eur J Heart Fail; 2017 May; 19(5):635-642. PubMed ID: 28485550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative.
    Agewall S; Tjessem LH; Rossignol P; Zannad F; Atar D; Lamiral Z; Machu JL; Dickstein K; Kjekshus J; von Lueder TG; Girerd N;
    Int J Cardiol; 2017 Dec; 249():274-281. PubMed ID: 28964557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.
    Pitt B; White H; Nicolau J; Martinez F; Gheorghiade M; Aschermann M; van Veldhuisen DJ; Zannad F; Krum H; Mukherjee R; Vincent J;
    J Am Coll Cardiol; 2005 Aug; 46(3):425-31. PubMed ID: 16053953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure: findings from the EPHESUS and OPTIMAAL trials.
    Ferreira JP; Duarte K; Pitt B; Dickstein K; McMurray JJV; Zannad F; Rossignol P
    J Hypertens; 2018 Aug; 36(8):1736-1742. PubMed ID: 29683884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study.
    Meris A; Amigoni M; Uno H; Thune JJ; Verma A; Køber L; Bourgoun M; McMurray JJ; Velazquez EJ; Maggioni AP; Ghali J; Arnold JM; Zelenkofske S; Pfeffer MA; Solomon SD
    Eur Heart J; 2009 Jan; 30(1):56-65. PubMed ID: 19001474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.
    Stephenson K; Skali H; McMurray JJ; Velazquez EJ; Aylward PG; Kober L; Van de Werf F; White HD; Pieper KS; Califf RM; Solomon SD; Pfeffer MA
    Heart Rhythm; 2007 Mar; 4(3):308-13. PubMed ID: 17341394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction database.
    Hui SK; Sharma A; Docherty K; McMurray JJV; Pitt B; Dickstein K; Pfeffer MA; Girerd N; Rossignol P; Ferreira JP; Zannad F
    Eur Heart J Acute Cardiovasc Care; 2021 Apr; 10(2):127-131. PubMed ID: 33620418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
    Lewis EF; Velazquez EJ; Solomon SD; Hellkamp AS; McMurray JJ; Mathias J; Rouleau JL; Maggioni AP; Swedberg K; Kober L; White H; Dalby AJ; Francis GS; Zannad F; Califf RM; Pfeffer MA
    Eur Heart J; 2008 Mar; 29(6):748-56. PubMed ID: 18308687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A history of systemic hypertension and incident heart failure hospitalization in patients with acute myocardial infarction and left ventricular systolic dysfunction.
    Ahmed A; Pitt B
    Am J Cardiol; 2009 May; 103(10):1374-80. PubMed ID: 19427431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
    Amigoni M; Meris A; Thune JJ; Mangalat D; Skali H; Bourgoun M; Warnica JW; Barvik S; Arnold JM; Velazquez EJ; Van de Werf F; Ghali J; McMurray JJ; Køber L; Pfeffer MA; Solomon SD
    Eur Heart J; 2007 Feb; 28(3):326-33. PubMed ID: 17251259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
    Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA;
    Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.